Galmed Pharmaceuticals Ltd. Holds Annual Shareholder Meeting
Ticker: GLMD · Form: 6-K · Filed: Jul 18, 2024 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | Jul 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Galmed Pharma held its shareholder meeting on July 17, 2024, voting on proposals from the proxy statement.
AI Summary
On July 17, 2024, Galmed Pharmaceuticals Ltd. held its Annual General Meeting of Shareholders. Shareholders voted on all proposals that were previously outlined in the company's proxy statement.
Why It Matters
This filing indicates that Galmed Pharmaceuticals Ltd. has completed its annual shareholder meeting, a routine corporate governance event where key decisions are made and shareholder input is formally gathered.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding an annual shareholder meeting and does not introduce new financial or operational risks.
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Registrant
- July 17, 2024 (date) — Date of Annual General Meeting
FAQ
What was the purpose of the Form 6-K filing?
The Form 6-K filing reports on the proceedings of Galmed Pharmaceuticals Ltd.'s Annual General Meeting of Shareholders held on July 17, 2024.
When did Galmed Pharmaceuticals Ltd. hold its Annual General Meeting of Shareholders?
The Annual General Meeting of Shareholders was held on July 17, 2024.
What did the shareholders vote on at the meeting?
Shareholders voted on all proposals that were described in the company's proxy statement.
Is Galmed Pharmaceuticals Ltd. required to file annual reports on Form 20-F or 40-F?
Yes, Galmed Pharmaceuticals Ltd. indicated it files annual reports under cover of Form 20-F.
What is the principal executive office address for Galmed Pharmaceuticals Ltd.?
The principal executive offices are located at c/o Meitar Law Offices, Abba Hillel Silver Rd., Ramat Gan, 5250608.
Filing Stats: 304 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2024-07-18 16:30:17
Filing Documents
- form6-k.htm (6-K) — 15KB
- 0001493152-24-028342.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Galmed Pharmaceuticals Ltd. Date: July 18, 2024 By: /s/ Allen Baharaff Allen Baharaff President and Chief Executive Officer